Insights into Company

Godavari Biorefineries Limited

📍 Mumbai, Maharashtra, India Active NSE GODAVARIB CIN L67120MH1956PLC009707 Oil, Gas & Energy
Search companies

Key Metrics of Godavari Biorefineries Limited

Revenue₹1,965 Cr▲ 6.0% YoYFY 2025-26
EBITDA₹104 Cr▼ 10.1% YoY
Net profit₹1.24 Cr▲ 104.6% YoY
Net worth₹773 Cr▲ 0.1% YoY
Competitors10identified

About Godavari Biorefineries Limited

Sectors

Oil, Gas & EnergyOil Refining & Marketing

Company details

Registered office
Somaiya Bhavan, 45/47, M.g. Road, Fort, Mumbai, Mumbai, In-mh, 400001
Listed
NSE: GODAVARIB · ₹222.42

Operational Areas of Godavari Biorefineries Limited

Oil, Gas & Energy›Oil Refining & Marketing

Company summary

Entity details

CINL67120MH1956PLC009707
LEI code335800HKLWUUCQI1DF36
State codeMH
PIN code400001
Current legal nameGODAVARI BIOREFINERIES LIMITED
Classification—
Listing statusListed (NSE: GODAVARIB)
Registration no.009707
Company age—
PAN—
CountryIndia
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code67120
Description of main activityActivities auxiliary to financial intermediation (broking, advisory)
Description of business activityActivities auxiliary to financial intermediation (broking, advisory)
SectorOil, Gas & Energy · Oil Refining & Marketing
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 7 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 37 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 17 Mar 2026 CARE BBB+ Stable outlook · Short term A2 · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on record▲ 2 notchessince Apr 2019
Rating actions121 up · 0 down
Liquidity (CARE)Adequate

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
17 Mar 2026CAREReaffirmed BBB+A2Stable₹836 Cr View
09 Jan 2025CAREUpgraded (from BBB) BBB+A2Stable₹836 Cr View
20 Oct 2023CAREReaffirmed BBBA3+Stable₹973 Cr View
09 Oct 2023CAREReaffirmed BBBA3+Stable₹963 Cr View
09 Nov 2022CAREReaffirmed BBBA3+Stable₹888 Cr View
22 Jun 2022CAREOther ———— View
04 Apr 2022CAREReaffirmed BBB—Stable₹75.0 Cr View
19 Aug 2021CAREReaffirmed (from BBB) BBBA3+Stable₹60.0 Cr View
29 Apr 2021CAREReaffirmed BBBA3Positive₹60.0 Cr View
07 Apr 2021CAREReaffirmed BBB-A3Positive₹779 Cr View
03 Apr 2020CAREOther ———— View
05 Apr 2019CAREReaffirmed BBB-A3Stable₹1,661 Cr View

Credit strengths (CARE, Mar 2026)

+ Strong promoter group and a long-standing track record in the sugar industry

GBL belongs to the Somaiya group, which is among the oldest and well-established industrial houses in India with diversified interests in sugar and its allied products, alcohol and bulk organic chemicals, bio-based specialty chemicals, healthcare, social welfare and education, including the Somaiya group of institutions, among others. The promoters have demonstrated their willingness to financially support the company in the past. GBL was established by Late KJ Somaiya in 1939 as The Godavari Su

+ Favourable location with proximity to high-recovery sugarcane producing regions

GBL operates a fully integrated sugarcane processing facility at Sameerwadi, Karnataka, which houses sugar cane crushing, distillery, and co-generation power units. Additionally, the company runs a bio-based chemicals manufacturing plant at Sakarwadi, Maharashtra. The strategic location of these facilities in Maharashtra and Karnataka , regions known for high-recovery sugarcane, provides operational advantages over other parts of India. In FY25, the company achieved a gross recovery rate of 10.9

+ Fully integrated unit with diversified product portfolio ; rising contribution from bio -based specialty chemicals

GBL derives strength from its well -diversified product portfolio across the sugar value chain, encompassing sugar, co -generation, distillery, and bio -based chemicals. This diversification mitigates concentration risk and provides resilience against the cyc lical nature of the sugar industry. In FY25, sugar, distillery, and biochemicals contributed 36% (FY24: 33%; FY23: 34%), 31% (FY24: 33%; FY23: 31%), and 29% (FY24: 30%; FY23: 32%) of total revenue, respectively, with the balance from power

+ Sustained growth in scale of operations with moderate profitability

On a consolidated basis, GBL’s TOI rose to ₹1,870.25 crore in FY25 (FY24: ₹1,686.67 crore), primarily driven by ~20% growth in the sugar segment and modest single -digit growth across other segments. This improvement was largely supported by higher sales volumes, complemented by be tter realisations. With the reinstatement of sugar exports and increasing consumption , revenue from the sugar division is expected to maintain its upward trajectory. Additionally, despite India achieving 20% ethanol

Credit challenges

− Moderate debt coverage metrics and sizeable contingent liabilities

GBL’s debt coverage metrics , as reflected by total debt/PBILDT and PBILDT interest cover of 4.93x and 1.45x, respectively, in FY25 (PY: 5.53x and 1.77x, respectively), remain lower than rating category benchmarks primarily due to subdued operating profitability and relatively higher reliance on borrowings . While the overall gearing improved to 0.94x as on March 31, 2025 (PY: 2.79x) with substantial prepayment of term loans from IPO proceeds in FY25, incremental borrowings to fund the ongoing c

− Working capital -intensive operations

Being seasonal in nature, t he sugar industry has high working capital requirements in the peak season, which is from November to April, to procure their primary raw material, sugarcane and manufacture sugar in this period. Moreover, the farmers’ dues need to be cleared in a timely manner owing to regulatory oversight, increasing the overall working capital intensity of operation s. GBL exports products on an advance basis and the collection period for the domestic sale of sugar to institutional

− Project implementation and stabilisation risk

The company is undertaking a planned capex towards setting up a 200 kilo litres per day (KLPD) grain-based distillery and debottlenecking of existing manufacturing facilities, partly funded by incremental borrowings . The grain-based distillery project, with fungible feedstock capacity, is scheduled to be commercialised in Q1 FY27 and benefit the company in terms of diversification of ethanol feedstock, reduce dependence on sugar syrup/molasses, increase distillery capacity and enhance operating

− Seasonal, cyclical, and regulated nature of sugar business

The sugar industry directly depends on the sugarcane crop and its yield, and is susceptible to agro -climatic risks. Climatic conditions, more specifically, the monsoons, influence operational parameters for a sugar entity, such as the crushing period and sugar recovery levels. Also, the degree of dispersion of monsoon precipitation across the sugar -growing areas also leads to fluctuating trends in sugar production in different regions. CareEdge Ratings notes that while the gross recovery rates

Could lead to an upgrade

• Substantial increase in scale of operations and improvement in PBILDT margin above 10% on a sustained basis. • Improvement in total debt to PBILDT below 2.5x on a sustained basis.

Could lead to a downgrade

• Total debt to PBILDT above 3.5x on a sustained basis. • Weaker-than-anticipated profitability and/or cash accruals leading to deterioration in the debt coverage indicators and

Agency-reported financials (CARE, 17 Mar 2026)

MetricMarch 31, 2024March 31, 20259MFY26
Total operating income₹1,687 Cr₹1,870 Cr₹1,424 Cr
PBILDT*₹134 Cr₹104 Cr₹40.91 Cr
Profit after tax (PAT)₹12.30 Cr₹-23.41 Cr₹-49.36 Cr
Overall gearing (x)2.79×0.94×—
Interest coverage (x)1.77×1.45×1.08×
Revenue growth (YoY)—10.9%—
PAT margin0.7%−1.3%−3.5%

Borrowings & rated debt

Rated borrowing limits (latest)₹836 Cr
Peak rated limits₹1,661 CrApr 2019 · CARE
Limits raised0 times0 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹654 Cr— BBB+ (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹97.0 Cr— A2ReaffirmedCARE
Fixed depositFixed deposits—₹85.0 Cr— BBB+ (Stable)ReaffirmedCARE

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
BG/LC₹97.0 CrCARE A2
Cash Credit₹276 CrCARE BBB+; Stable
Fixed Deposit₹85.0 CrCARE BBB+; Stable
Non Convertible Debentures—Withdrawn
Term Loan₹378 CrCARE BBB+; Stable

Lenders

Fund-based - LTCash CreditBank of India
Fund-based - LTCash CreditIndusInd Bank Ltd.
Fund-based - LTCash CreditUnion Bank of India
Fund-based - LTCash CreditYes Bank Ltd.
Fund-based - LTTerm LoanBandhan Bank Ltd.
Fund-based - LTTerm LoanBank of India
Fund-based - LTTerm LoanIndusInd Bank Ltd.
Fund-based - LTTerm LoanProposed
Fund-based - LTTerm LoanSVC Co-operative Bank Ltd
Fund-based - LTTerm LoanUnion Bank of India
Non-fund-based - STBG/LCBank of India
Non-fund-based - STBG/LCIndusInd Bank Ltd.
Non-fund-based - STBG/LCUnion Bank of India
Non-fund-based - STBG/LCYes Bank Ltd.

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26
Indicative long-term—
Indicative short-term—
Score—
LiquidityStretchedAgency: Adequate
DirectionStableAgency outlook: Stable
CARE rating · Mar 2026BBB+Matches indicative band

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)70%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 70% (Mostly stable) · scorecard until enough rating history is collected
Rated limits₹836 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage1.08×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 70% chance the next rating action is stable or better
  • Current rating BBB+ (investment grade)
  • Interest coverage 1.08×

Rated limits by facility

Timeline

17 Mar 2026 CARE reaffirmed: BBB+ (Stable)Rated limits ₹835.83 cr CARE rationale
09 Jan 2025 CARE upgraded: BBB+ (Stable)Rated limits ₹835.83 cr CARE rationale
20 Oct 2023 CARE reaffirmed: BBB (Stable)Rated limits ₹972.94 cr CARE rationale
09 Oct 2023 CARE reaffirmed: BBB (Stable)Rated limits ₹962.94 cr CARE rationale
09 Nov 2022 CARE reaffirmed: BBB (Stable)Rated limits ₹888 cr CARE rationale
22 Jun 2022 CARE other: — CARE rationale
04 Apr 2022 CARE reaffirmed: BBB (Stable)Rated limits ₹75 cr CARE rationale
19 Aug 2021 CARE reaffirmed: BBB (Stable)Rated limits ₹60 cr CARE rationale
29 Apr 2021 CARE reaffirmed: BBB (Positive)Rated limits ₹60 cr CARE rationale
07 Apr 2021 CARE reaffirmed: BBB- (Positive)Rated limits ₹779.33 cr CARE rationale
03 Apr 2020 CARE other: — CARE rationale
05 Apr 2019 CARE reaffirmed: BBB- (Stable)Rated limits ₹1,661 cr CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeSOMAIYA BHAVAN, 45/47, M.G. ROAD, FORT, MUMBAI, MUMBAI, IN-MH, 400001
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Godavari Biorefineries Limited

Competitors10identified
Locations3most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Indian Oil Corporation Outlets operated by Indian Oil. iocl.com 1964 Mumbai, India
Oil and Natural Gas Corporation Oil Refining & Marketing · Oil, Gas & Energy ongcindia.com 1955 New Delhi, India
GAIL (India) Outlets operated by GAIL. gailonline.com — New Delhi, India
Mangalore Refinery and Petrochemicals (MRPL) Oil Refining & Marketing · Oil, Gas & Energy mrpl.co.in — India
Chennai Petroleum Corporation Oil Refining & Marketing · Oil, Gas & Energy cpcl.co.in 1965 Madras, India
Petronet LNG Oil Refining & Marketing · Oil, Gas & Energy petronetlng.com — New Delhi, India
Oil India Oil Refining & Marketing · Oil, Gas & Energy oilindia.nic.in 1959 Dibrugarh, India
Indraprastha Gas Outlets operated by Indraprasath. iglonline.net — New Delhi, India
Bharat Coking Coal Limited Stainless Steel & Non-Ferrous Metals · Steel, Metals & Pipes — — Dhanbad, Jharkhand, India
Aegis Logistics Limited Outlets operated by Aegis Logistics. — — Vapi, Maharashtra, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.